Patents by Inventor Kensei Yamaguchi

Kensei Yamaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers, test method, and test kit for predicting therapeutic effect of anti-VEGFR-2 antibody drug
    Patent number: 11415584
    Abstract: The therapeutic effect of and/or prognosis after administration of an anti-VEGFR-2 antibody drug, in particular, ramucirumab can be predicted by measuring VEGF-A, VEGF-D, sVEGFR-2, SDF-1?, and/or cNRP1. Provided is a biomarker for predicting the effect of administration of the anti-VEGFR-2 antibody drug, in particular, ramucirumab, and a test method and a test kit using the marker.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: August 16, 2022
    Assignee: JAPANESE FOUNDATION FOR CANCER RESEARCH
    Inventors: Tetsuo Mashima, Takeru Wakatsuki, Hiroyuki Seimiya, Kensei Yamaguchi
  • BIOMARKERS, TEST METHOD, AND TEST KIT FOR PREDICTING THERAPEUTIC EFFECT OF ANTI-VEGFR-2 ANTIBODY DRUG
    Publication number: 20200355699
    Abstract: The therapeutic effect of and/or prognosis after administration of an anti-VEGFR-2 antibody drug, in particular, ramucirumab can be predicted by measuring VEGF-A, VEGF-D, sVEGFR-2, SDF-1?, and/or cNRP1. Provided is a biomarker for predicting the effect of administration of the anti-VEGFR-2 antibody drug, in particular, ramucirumab, and a test method and a test kit using the marker.
    Type: Application
    Filed: December 27, 2017
    Publication date: November 12, 2020
    Inventors: Tetsuo Mashima, Takeru Wakatsuki, Hiroyuki Seimiya, Kensei Yamaguchi